Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase

CONCLUSION: This analysis revealed that fosnetupitant could have long-acting antiemetic potency (> 120 h) and indicated the importance of antiemetic therapy at 0-120 h for CINV up to 168 h after chemotherapy.PMID:37715851 | DOI:10.1007/s12325-023-02648-1

Source: Adv Data - September 16, 2023 Category: Epidemiology Authors: Naoki Inui Yukihiro Toi Yasuto Yoneshima Masahiro Morise Akito Hata Kaoru Kubota Toshiaki Saeki Tomohide Tamura Source Type: research